Opus Genetics, Inc. (IRD) — Financial statements
Income statement, balance sheet, and cash flow for Opus Genetics, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 14↑29.1% | 11↓42.3% | 19↓52.2% | 40↑6665.7% | 0.59 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 14↑29.1% | 11↓42.3% | 19↓52.2% | 40↑6665.7% | 0.59 | |
| Operating Expenses | ||||||
| R&D Expenses | 31↑14.8% | 27↑52.1% | 18↑23.0% | 14↓5.4% | 15 | |
| General & Administrative Expenses | 22↑20.7% | 18↑52.3% | 12↑64.5% | 7↓10.5% | 8 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 22↑20.7% | 18↑52.3% | 12↑64.5% | 7↓10.5% | 8 | |
| Other Expenses | 0.00↓100.0% | 28 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 53↓27.7% | 73↑146.7% | 30↑36.9% | 22↓7.2% | 23 | |
| Total Costs & Expenses | 53↓27.7% | 73↑146.7% | 30↑36.9% | 22↓7.2% | 23 | |
| Operating Results | ||||||
| Operating Income | -39↑37.8% | -62↓487.7% | -11↓158.0% | 18↑180.3% | -23 | |
| Depreciation & Amortization | 0.05↑430.0% | 0.01↑66.7% | 0.01↑50.0% | 0.00↑0.0% | 0.00 | |
| EBITDA | -48↑16.4% | -58↓477.1% | -10↓154.7% | 18↑132.1% | -57 | |
| EBIT | -48↑16.4% | -58↓476.8% | -10↓154.8% | 18↑132.1% | -57 | |
| Interest & Other Income | ||||||
| Net Interest Income | -1 | 0.00↑100.0% | -1↓14655.6% | -0.01↓350.0% | -0.00 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 1 | 0.00↓100.0% | 1↑14655.6% | 0.01↑350.0% | 0.00 | |
| Non-Operating Income | 10↑309.7% | -5↓671.1% | -0.59↓4307.1% | 0.01↓100.0% | 34 | |
| Other Income / Expenses | -11↓342.0% | 5↑671.1% | 0.59↑2660.9% | -0.02↑99.9% | -34 | |
| Income Before Tax | -50↑13.8% | -58↓476.8% | -10↓154.8% | 18↑132.1% | -57 | |
| Income Tax Expense | 0.00 | 0.00↓100.0% | 0.01↓96.2% | 0.32 | 0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -50↑13.8% | -58↓476.1% | -10↓155.8% | 18↑131.6% | -57 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -50↑13.8% | -58↓476.1% | -10↓155.8% | 18↑131.6% | -57 | |
| Bottom-Line Net Income | -50↑13.8% | -58↓476.1% | -10↓155.8% | 18↑131.6% | -57 | |
| EPS (Basic) | -0.80↑62.8% | -2.15↓367.4% | -0.46↓151.1% | 0.90↑123.6% | -3.82 | |
| EPS (Diluted) | -0.80↑62.8% | -2.15↓367.4% | -0.46↓152.9% | 0.87↑122.8% | -3.82 | |
| Weighted Average Shares | 622↑2229.1% | 27↑23.7% | 22↑8.3% | 20↑34.2% | 15 | |
| Weighted Average Diluted Shares | 622↑2229.1% | 27↑23.7% | 22↑4.8% | 21↑38.7% | 15 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.